Treatment usually results in a cure even with advanced disease, but early detection of this cancer improves survival rates and allows for simpler treatment, often sparing the need for chemotherapy.
Prostate cancer is much more common than testicular cancer.
And screening for prostate cancer is very complicated and has recently become very controversial. Approximately 300,000 cases are diagnosed each year, mostly in men over 60, and currently 40,000 people die each year as a result of it. There are several reasons why screening for prostate cancer is fraught with frustration. Third, there has been no data yet that proves that early detection reduces mortality on a population basis. The current screening tests for prostate cancer are generally covered by insurance.